Device for conditioning ex vivo pericardial tissue

Information

  • Patent Grant
  • 12127757
  • Patent Number
    12,127,757
  • Date Filed
    Monday, December 23, 2019
    4 years ago
  • Date Issued
    Tuesday, October 29, 2024
    a month ago
Abstract
Embodiments of the present disclosure include a method for conditioning ex vivo pericardial tissue that has a parietal side and a fibrous side from which fibers extend. A blade assembly includes a blade head having a blade array and a face that defines gaps therein. The parietal side of the tissue is placed downward against a support plate, and a motor is operated to move the blade array with respect to the face. The face contacts the tissue such that the fibers protrude through the gaps and into the blade head. The blade array shears the fibers that protrude through the gaps into the blade head, yielding sheared fibers. Other embodiments are also described.
Description
CROSS-REFERENCES TO RELATED APPLICATIONS

The present application is the US national phase of PCT application IL2019/051398, which published as WO 2020/165889, and which claims priority from UK patent application 1901887.8 (now terminated before grant) to Albitov et al., filed Feb. 11, 2019, which is assigned to the assignee of the present application, and which is incorporated herein by reference.


FIELD OF THE INVENTION

Some applications of the present invention relate in general to techniques for conditioning ex vivo fibrous tissue. More specifically, some applications of the present invention relate to techniques for removing fibers from ex vivo pericardial tissue in order to prepare the tissue for subsequent incorporation, as a prosthetic leaflet, into a prosthetic heart valve.


BACKGROUND

Xenographic use of pericardial tissue from animal sources is common practice in implantation of prosthetic heart valves to human patients. Particularly, ex vivo pericardial tissue is often used as raw material for preparation of prosthetic heart valve leaflets.


SUMMARY OF THE INVENTION

The present invention is directed to apparatus and methods for conditioning ex vivo pericardial tissue, in particular, this conditioning can include removing fibers that extend from a fibrous side of the tissue.


Aspects of the present invention include apparatus and methods for removing fibers from ex vivo pericardial tissue using a blade assembly comprising a motor configured to receive electrical power and to power a drive shaft. The drive shaft operatively connects the motor to a blade head. The blade head comprises a blade array operatively connected to the drive shall to move the blade array. The blade head comprises a face defining gaps dimensioned to facilitate protrusion therethrough of the fibers into the blade head. Applying the electrically powered blade assembly to a surface of the tissue removes fibers from the tissue by moving the blade array, with respect to the face, shearing the fibers that protrude through the gaps into the blade head.


Some aspects of the present invention include a separate battery pack configured to transmit electrical power to the motor.


Some aspects of the present invention include a separate controller configured to control the motor by controlling transmission of electrical power to the motor.


Some aspects of the present invention include apparatus and methods for removing fibers from ex vivo pericardial tissue while the tissue is submerged in a liquid within a bath, with the fibers facing upward, with the blade head facing downward, and with the blade array submerged in the liquid. The blade-assembly housing is typically shaped to define an exhaust hole. While the blade array is submerged in the liquid, the liquid is sucked into the blade head, and discharges a refuse liquid through the exhaust hole. For some applications, this suction is provided by movement of the blade array by the motor. For some applications, a distinct pump is configured to discard the liquid via a refuse hose, and to supply fresh liquid to the tissue via an inlet hose.


There is therefore provided, in accordance with an application of the present invention, apparatus for conditioning ex vivo pericardial tissue, the tissue having a parietal side, and a fibrous side from which fibers extend, the apparatus including:

    • a blade assembly including:
      • a blade head that includes:
        • a blade array; and
        • a face, the face defining gaps therein, the gaps dimensioned to facilitate protrusion therethrough of the fibers into the blade head, such that movement of the blade array, with respect to the face, shears the fibers that protrude through the gaps into the blade head:
      • a motor;
      • a drive shaft, the drive shaft operatively connecting the motor to the blade array; and
      • a blade-assembly housing that houses the blade head, the motor, and the drive shaft;
    • and:
      • the blade assembly is configured to be used while the tissue is submerged in a liquid with the fibers facing upward, with the face facing downward, and with the blade array submerged in the liquid;
      • the blade-assembly housing is shaped to define an exhaust hole; and
      • the apparatus is configured to generate, while the blade array is submerged in the liquid, a suction force that sucks the liquid into the blade head via the gaps, and discharges a refuse liquid through the exhaust hole.


In an application, the apparatus includes a refuse hose connected to the exhaust hole, and leading away from the blade assembly.


In an application, the apparatus is configured such that movement of the blade array with respect to the face generates the suction force.


In an application, the apparatus is configured such that rotation of the blade array with respect to the face generates the suction force.


In an application, the apparatus includes a pump, the pump being:

    • fluidly connected to the exhaust hole; and
    • configured to generate the suction force.


In an application, the apparatus includes a refuse hose connected to the exhaust hole, and the pump is fluidly connected to the exhaust hole via the refuse hose.


In an application, the apparatus includes an inlet hose, the inlet hose configured to be connected to a source of fresh liquid, and the pump is:

    • connected to the inlet hose, and
    • configured to supply the fresh liquid to the tissue via the inlet hose.


In an application, the apparatus includes a controller pack, the controller pack including a controller, the controller configured to control transmission of electrical power to the pump.


In an application, the controller is configured to receive the power from a battery.


In an application, the controller is configured to receive the power from an external power input.


In an application:

    • the blade assembly includes a distal end, a proximal end, and a longitudinal axis therebetween;
    • the blade head is disposed at the distal end, and
    • the exhaust hole is disposed laterally to the longitudinal axis, the apparatus being configured to discharge the refuse liquid laterally through the exhaust hole.


In an application, the exhaust hole is disposed proximal from the blade head.


In an application, the blade assembly housing defines a handle proximal from the blade head.


There is further provided, in accordance with an application of the present invention, apparatus for conditioning ex vivo pericardial tissue, the tissue having a parietal side, and a fibrous side from which fibers extend, the apparatus including:

    • a blade assembly including:
      • a blade head including:
        • a blade array; and
        • a face, the face defining gaps therein, the gaps dimensioned to facilitate protrusion therethrough of the fibers into the blade head, such that movement of the blade array with respect to the face, shears the fibers that protrude through the gaps into the blade head;
      • a drive shaft;
      • a motor, operatively coupled to the blade array via the drive shaft, so as to be configured to move the blade array relative to the face;
      • a blade-assembly housing that houses the blade head, the motor, and the drive shaft;
    • a battery pack; and
    • a flexible electrical cord flexibly coupling the battery pack to the blade-assembly housing thereby facilitating movement of the blade assembly in relation to the battery pack, and electrically connecting the battery back to the motor.


In an application, the apparatus includes a battery housed within the battery pack.


In an application, the motor is operatively coupled to the blade array via the drive shaft, so as to be configured to rotate the blade array relative to the face.


In an application, the blade assembly does not include a battery.


In an application, the cord is reversibly connectable to the battery pack.


In an application, the cord is reversibly connectable to the blade assembly.


In an application:

    • the blade assembly is configured to be used while the tissue is submerged in a liquid, with the fibers facing upward, with the face facing downward, and with the blade array submerged in the liquid;
    • the blade-assembly housing is shaped to define an exhaust hole; and
    • the apparatus is configured to generate, while the blade array is submerged in the liquid, a suction force that sucks the liquid into the blade head via the gaps, and discharges a refuse liquid through the exhaust hole.


In an application, the apparatus includes a refuse hose connected to the exhaust hole, and leading away from the blade assembly.


In an application, the apparatus is configured such that movement of the blade array with respect to the face generates the suction force.


In an application, the apparatus is configured such that rotation of the blade array with respect to the face generates the suction force.


In an application, the apparatus includes a pump, the pump being:

    • fluidly connected to the exhaust hole; and
    • configured to generate the suction force.


In an application, the apparatus includes a refuse hose connected to the exhaust hole, and the pump is fluidly connected to the exhaust hole via the refuse hose.


In an application, the apparatus includes an inlet hose, the inlet hose configured to be connected to a source of fresh liquid, and the pump is:

    • connected to the inlet hose, and
    • configured to supply the fresh liquid to the tissue via the inlet hose.


In an application:

    • the blade assembly includes a distal end, a proximal end, and a longitudinal axis therebetween;
    • the blade head is disposed at the distal end, and


the exhaust hole is disposed laterally to the longitudinal axis, the apparatus being configured to discharge the refuse liquid laterally through the exhaust hole.


In an application, the exhaust hole is disposed proximal from the blade bead.


In an application, the blade assembly housing defines a handle proximal from the blade head.


In an application, the battery pack includes a controller, and the controller is configured to control the motor.


In an application, the controller is configured to control transmission of power from the battery to the motor.


In an application, the controller includes a variable resistor.


In an application, the blade assembly includes a controller, and the controller is configured to control the motor.


In an application, the controller is configured to control transmission of power from the battery to the motor.


In an application, the controller includes a variable resistor.


There is further provided, in accordance with an application of the present invention, apparatus for conditioning ex vivo pericardial tissue, the tissue having a parietal side, and a fibrous side from which fibers extend, the apparatus including:

    • a blade assembly including:
      • a blade head that includes:
        • a blade array; and
        • a face, the face defining gaps therein, the gaps dimensioned to facilitate protrusion therethrough of the fibers into the blade head, such that movement of the blade array with respect to the face shears the fibers that protrude through the gaps into the blade head;
      • a motor,
      • a drive shaft, the drive shaft operatively connecting the motor to the blade array; and
      • a blade-assembly housing that houses the blade head, the motor, and the drive shaft;
      • a controller pack, the controller pack including a controller, the controller configured to control the motor; and
    • a flexible electrical cord electrically connecting the controller pack to the blade-assembly housing, thereby facilitating movement of the blade assembly in relation to the controller pack, the controller pack being configured to power, via the cord, the motor to move the blade array relative to the face.


In an application, the controller is configured to power the motor to move the blade array rotationally, relative to the face.


In an application, the apparatus includes a battery, the battery being configured to power the controller pack.


In an application, the battery is co-housed with the controller in the controller pack.


In an application, the controller is configured to control transmission of power from the battery to the motor.


In an application, the controller includes a variable resistor.


In an application, the cord is reversibly connectable to the controller pack.


In an application, the cord is reversibly connectable to the blade assembly.


In an application:

    • the blade assembly is configured to be used while the tissue is submerged in a liquid, with the fibers facing upward, with the face facing downward, and with the blade array submerged in the liquid;
    • the blade-assembly housing is shaped to define an exhaust hole; and
    • the apparatus is configured to generate, while the blade array is submerged in the liquid, a suction force that sucks the liquid into the blade head via the gaps, and discharges a refuse liquid through the exhaust hole.


In an application, the apparatus includes a refuse hose connected to the exhaust hole, and leading away from the blade assembly.


In an application, the apparatus is configured such that movement of the blade array with respect to the face generates the suction force.


In an application, the apparatus is configured such that rotation of the blade array with respect to the face generates the suction force.


In an application, the apparatus includes a pump, the pump being:

    • fluidly connected to the exhaust hole; and
    • configured to generate the suction force.


In an application, the apparatus includes a refuse hose connected to the exhaust hole, and the pump is fluidly connected to the exhaust hole via the refuse hose.


In an application, the apparatus includes an inlet hose, the inlet hose configured to be connected to a source of fresh liquid, and the pump is:

    • connected to the inlet hose, and
    • configured to supply fresh liquid to the tissue via the inlet hose.


In an application:

    • the blade assembly includes a distal end, a proximal end, and a longitudinal axis therebetween;
    • the blade head is disposed at the distal end, and
    • the exhaust hole is disposed laterally to the longitudinal axis, the apparatus being configured to discharge the refuse liquid laterally through the exhaust hole.


In an application, the exhaust hole is disposed proximal from the blade head.


In an application, the blade assembly housing defines a handle proximal from the blade head.


There is further provided, in accordance with an application of the present invention, a system for conditioning ex vivo pericardial tissue, the tissue having a parietal side, and a fibrous side from which fibers extend, the system including:

    • a blade assembly including:
      • a blade head that includes:
        • a blade array; and
        • a face, the face defining gaps therein, the gaps dimensioned to facilitate protrusion therethrough of the fibers into the blade head, such that movement of the blade array, with respect to the face, shears the fibers that protrude through the gaps into the blade head;
      • a motor;
      • a drive shaft, the drive shaft operatively connecting the motor to the blade array; and
      • a blade-assembly housing that houses the blade head, the motor, and the drive shaft;
    • a bath; and
    • a tissue restraint, configured to secure the tissue within the bath.


In an application, the apparatus includes a support plate, and the tissue restraint is configured to secure the tissue to the support plate, the support plate being configured to support the tissue, and the bath being dimensioned to receive a portion of the support plate.


In an application, the bath has a floor, the floor defining a recess, the recess shaped to receive the portion of the plate.


In an application, the tissue restraint includes at least one bracket


In an application, the bracket and the plate each include holes, the holes of the bracket and the holes of the plate being aligned complementarily.


In an application:

    • the bath has a floor, the floor defining a recess dimensioned to snugly receive the tissue, and
    • the tissue restraint is coupled to the bath, and is configured to secure the tissue within the recess.


In an application, the tissue restraint includes at least one bracket.


In an application:

    • the blade assembly is configured to be used while the tissue is submerged in a liquid with the fibers facing upward, with the face facing downward, and with the blade array submerged in the liquid;
    • the blade-assembly housing is shaped to define an exhaust hole; and
    • the blade assembly is configured to generate, while the blade array is submerged in the liquid, a suction force that sucks the liquid into the blade head via the gaps, and discharges a refuse liquid through the exhaust hole.


In an application, the apparatus includes a refuse hose connected to the exhaust hole, and leading away from the blade assembly.


In an application, the apparatus is configured such that movement of the blade array with respect to the face generates the suction force.


In an application, the apparatus is configured such that rotation of the blade array with respect to the face generates the suction force.


In an application, the apparatus includes a pump, the pump being:

    • fluidly connected to the exhaust hole; and
    • configured to generate the suction force.


In an application, the apparatus includes a refuse hose connected to the exhaust hole, and the pump is fluidly connected to the exhaust hole via the refuse hose.


In an application, the apparatus includes an inlet hose, the inlet hose configured to be connected to a source of fresh liquid, and the pump is:

    • connected to the inlet hose, and
    • configured to supply the fresh liquid to the tissue via the inlet hose.


In an application:

    • the blade assembly includes a distal end, a proximal end, and a longitudinal axis therebetween;
    • the blade head is disposed at the distal end, and
    • the exhaust hole is disposed laterally to the longitudinal axis, the apparatus being configured to discharge the refuse liquid laterally through the exhaust hole.


In an application, the exhaust hole is disposed proximal from the blade head.


In an application, the blade assembly housing defines a handle proximal from the blade head.


In an application, the apparatus includes a controller pack, the controller pack including a controller configured to control the motor.


In an application, the controller is configured to control transmission of power from a battery to the motor.


In an application, the controller includes a variable resistor.


In an application, the blade assembly includes a controller, and the controller is configured to control the motor.


In an application, the controller is configured to control transmission of power from a battery to the motor.


In an application, the controller includes a variable resistor.


There is further provided, in accordance with an application of the present invention, a method for conditioning ex vivo pericardial tissue, the tissue having a parietal side, and a fibrous side from which fibers extend, the method including:

    • providing a blade assembly, the blade assembly including a blade head, the blade head including a blade array and a face, the face defining gaps therein;
    • placing the parietal side of the tissue downward against a support plate;
    • operating a motor to move the blade array with respect to the face; and
    • contacting the face with the tissue such that the fibers protrude through the gaps into the blade head, and the blade array shears the fibers that protrude through the gaps into the blade head, yielding sheared fibers.


In an application, the method includes mechanically securing the tissue to the support plate using a tissue restraint.


In an application, contacting the face with the tissue includes contacting the face with a first portion of the tissue, and the method includes subsequently contacting the face with a second portion of the tissue.


In an application, the method includes:

    • adding a liquid to a bath,
    • submerging the tissue in the liquid within the bath, with the fibers facing upward, and
    • contacting the face with the tissue includes contacting the face with the tissue with the face facing downward.


In an application,

    • the bath is dimensioned to define a built-in support plate, and
    • placing the tissue involves placing the tissue against the built-in support plate.


In an application, submerging the face of the blade head in the liquid within the bath.


In an application, the bath has a floor defining a recess dimensioned to snugly receive the plate, and the method includes fitting the plate and the tissue into the recess.


In an application:

    • the blade-assembly housing defines an exhaust hole,
    • applying the blade assembly to the tissue includes submerging the face and the blade array in a liquid; and
    • the method includes generating a suction force that:
    • sucks the liquid into the blade head via the gaps, and
    • discharges, through the exhaust hole, a refuse liquid including the liquid and
    • the sheared fibers.


In an application, discharging the refuse liquid includes flushing the sheared fibers, with the refuse liquid, out from the blade-assembly housing, laterally through the exhaust hole.


In an application, the method includes draining the refuse liquid via a refuse hose.


In an application, generating the suction force includes generating the suction force using a pump, the pump being fluidly connected to the exhaust hole.


In an application, the method includes discarding, using the pump, the refuse liquid via a refuse hose that fluidly connects the pump to the exhaust hole.


In an application, the method includes supplying fresh liquid to the tissue via an inlet hose.


In an application, supplying fresh liquid to the tissue includes supplying, using the pump, the fresh liquid via an inlet hose that fluidly connects the pump to the tissue.


In an application:

    • the blade-assembly housing defines an exhaust hole,
    • applying the blade assembly to the tissue includes submerging the face and the blade array in a liquid; and
    • operating the motor includes operating the motor such that movement of the blade array with respect to the face generates a suction force that:
    • sucks the liquid into the blade head via the gaps, and
    • discharges, through the exhaust hole, a refuse liquid including the liquid and
    • the sheared fibers.


In an application, operating the motor includes operating the motor such that rotation of the blade array with respect to the face generates the suction force.


In an application, operating the motor includes controlling transmission of electrical power to the motor via a controller.


In an application, controlling the transmission of electrical power includes controlling the transmission of electrical power using a controller pack that is flexibly connected to the blade assembly via a flexible cord.


The present invention will be more fully understood from the following detailed description of applications thereof, taken together with the drawings, in which:





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a schematic illustration of a device comprising a blade assembly, the blade assembly flexibly connected to a controller pack comprising a battery pack and a contoller, in accordance with some applications of the present, invention;



FIG. 2 is a schematic illustration of a device comprising a blade assembly, the blade assembly flexibly connected to a controller pack comprising a controller, in accordance with some applications of the present invention;



FIG. 3 is a schematic illustration of a device comprising a blade assembly, the blade assembly comprising a controller, and flexibly connected to a battery pack, in accordance with some applications of the present invention;



FIGS. 4A-C are schematic illustrations of a support plate and a tissue restraint for inserting ex vivo pericardial tissue into a bath, in accordance with some applications of the present invention; and



FIGS. 5A-B are schematic illustrations of ex vivo pericardial tissue secured to a support plate, the plate and tissue submerged in a liquid within a bath for removal of fibers from the tissue by applying an electrically powered blade assembly to the tissue, in accordance with some applications of the present invention.





DETAILED DESCRIPTION OF EMBODIMENTS

Reference is made to FIGS. 1-3, which are schematic illustrations of a device 10 for conditioning ex vivo pericardial tissue 110, in accordance with some applications of the invention. In particular, device 10 is used for removing fibers from the fibrous side of the pericardium. This may be performed in order to prepare the tissue for subsequent incorporation, as a prosthetic leaflet, into a prosthetic heart valve.


Typically, and as shown, device 10 comprises a blade assembly 20 having a longitudinal axis ax18, that comprises a blade head 26 on a distal end 46 of the blade assembly, and a handle 44 at a proximal portion 48 of the blade assembly. Blade assembly 20 typically comprises a blade-assembly housing 22 that houses the other components of the blade assembly. Blade assembly 20 is typically hand-held, e.g., having a length of 5-20 cm, a maximum width of 1-10 cm, and/or a weight of 0.05-1 kg (e.g., 50-500 g, such as 50-200 g). For some applications, blade assembly 20 (e.g., housing 22) is configured (e.g., dimensioned and/or shaped) to be held like a pen, e.g., to facilitate finely controlled movement of the blade assembly by the user. Blade head 26 comprises a face 30, which defines gaps 32, which are dimensioned to facilitate protrusion therethrough of the fibers into blade head 26. A blade array 28 is disposed within blade head 26, adjacent to and proximal of face 30. Blade array 28 is operatively connected to a motor 40 via a drive shaft 42. Typically, and as shown, drive shaft 42 is disposed along longitudinal axis ax18. When in operation, motor 40 moves (e.g. rotates) blade array 28, relative to face 30, shearing fibers that protrude through gaps 32 into blade head 26.


For some applications, and as shown in FIGS. 1 and 3, device 10 comprises a battery pack 60 that houses, or is configured to house, a battery 64. For some applications, and as shown, battery 64 may comprise one or more commercially-available batteries, typically supplied by the user. For other applications, battery pack 60 comprises battery 64, which may or may not be integral to battery pack 60. For such applications, battery 64 is typically rechargeable.


For such applications, battery pack 60 is flexibly connected to blade assembly 20 by a flexible electrical cord 78, the flexibility of the cord facilitating movement of the blade assembly in relation to the battery pack. Battery 64 powers motor 40 via cord 78. That is, cord 78 electrically connects battery 64 to motor 40. For some applications, cord 78 is reversibly connectable to battery pack 60, and/or to blade assembly 20. Typically, and as shown, blade assembly 20 does not comprise a battery.


Typically, and as shown in FIGS. 1, 2, and 3, device 10 comprises a controller 74.


Controller 74 controls motor 40, e.g., by controlling electrical power that is transmitted to the motor. For some applications, controller 74 comprises a variable resistor, although other means for regulating electrical power are also contemplated. For some applications, controller 74 is a switch, e.g., having discrete states, such as an on/off switch, or a switch that provides discrete motor speeds.


Typically, controller 74 comprises a control dial, knob or switch. Although the FIGS. 1, 2, and 3 referred to herein depict controller 74 as comprising a dial serving as a user interface, this depiction is not intended to exclude other possible user interfaces, be they mechanical (e.g. buttons or levers), electronic (e.g., touchscreen) or other.


For some applications, e.g., as shown in FIGS. 1 and 2, controller 74 is housed by a controller pack 70, e.g., flexibly coupled and electrically connected to blade assembly 20 via cord 78. In some applications, adjusting controller 74 variably regulates electrical power that is transmitted from controller pack 70, via flexible electrical cord 78, to motor 40 of blade assembly 20. For example, and as shown in FIG. 1, controller 74 may be co-housed with battery 64, e.g., such that battery pack 60 also serves as a controller pack 70.


Alternatively, and as shown in FIG. 2, controller pack 70, comprising controller 74, may be provided independently of a battery pack. Similarly to as described above in reference to battery pack 60, flexible connection of controller pack 70 to blade assembly 20 via flexible cord 78 facilitates movement of the blade assembly in relation to the controller pack. In the embodiment shown in FIG. 2, controller 74 powers motor 40 via cord 78. That is, cord 78 electrically connects controller 74 to motor 40. For some applications, cord 78 is reversibly connectable to contoller pack 70, and/or to blade assembly 20.


For some applications, and as shown in FIG. 2, battery pack 60 is absent. Typically, for applications lacking battery pack 60, and as shown, an external power cord 82 supplies electrical power, at a power input 84 of controller pack 70.


For other applications, as illustrated in FIG. 3, blade assembly 20 comprises controller 74. For such applications, controller 74 typically receives electrical power, via cord 78, from battery pack 60. For some applications, adjusting controller 74 typically variably regulates electrical power that is transmitted to motor 40 of blade assembly 20.


Reference is made to FIGS. 4A-C, which are schematic illustrations of a support plate 100 and a tissue restraint 102 being used to submerge ex vivo pericardial tissue 110 in a liquid 126 within a bath 120, in accordance with some applications of the invention.


For some applications, and as shown, ex vivo pericardial tissue 110 is placed against support plate 100, and is mechanically secured to the support plate by attaching a tissue restraint 102 to the plate. Typically, and as shown, a parietal side of tissue 110 is placed downward against plate 100, exposing a fibrous side 112 of the tissue, from which fibers 114 extend upwards.


For some applications, and as shown in FIG. 4C, tissue 110, secured to plate 100, is placed into a bath 120. Typically, bath 120 is dimensioned to facilitate submerging tissue 110 in a liquid 126 within the bath. For some applications, and as shown, bath 120 is dimensioned to define a recess 124 in a floor 128 of the bath. Typically, plate 100, tissue restraint 102 and tissue 110 are fitted into recess 124 by the user.


For some applications, and as shown, tissue restraint 102 comprises at least one bracket, configured to secure the tissue to the plate. As shown, for such applications the support plate and the brackets typically comprise holes 106 aligned complementarily to facilitate mechanical fastening of the brackets to the plate (e.g. by screws 104). However, it is to be noted that the scope of the invention includes other mechanisms for securing tissue 110 to plate 100, such as clamps.


As shown in FIG. 4C, recess 124 is dimensioned to snugly receive plate 100. In other applications (not shown), recess 124 is dimensioned to define a built-in support plate configured to snugly receive tissue 110, and the tissue is affixed to the built-in support plate. In such applications, tissue restraint 102 is typically coupled to bath 120.


Reference is made to FIGS. 5A-B, which are schematic illustrations showing shearing of fibers 114 from tissue 110 using blade assembly 20, in accordance with some applications of the invention. Typically, and as shown, this is performed while the tissue is submerged in liquid 126 within bath 120.


Typically, and as shown in FIG. 5A, bath 120 comprises side-walls 130 extending upward from floor 128, facilitating submerging tissue 110 in liquid 126 within bath 120. Typically, and as shown, tissue 110 is submerged in liquid 126 with fibrous side 112 (and therefore fibers 114) facing upward.


Typically, face 30 of blade head 26 on distal end 46 of blade assembly 20 is applied downward upon fibrous side 112 of tissue 110, such that upward-extending fibers 114 protrude through gaps 32 into blade head 26. In inset “b” of FIG. 5A, reference numeral 114a indicates fibers that have not yet been contacted by assembly 20, and reference numeral 114b indicates fibers that protrude through gaps 32 in face 30, prior to shearing. As described hereinabove, motor 40 moves (e.g., rotates) blade array 28, relative to face 30, so as to shear fibers 114b. Reference numeral 114c indicates sheared ends 114c of the fibers, and reference numeral 114d indicates the residual base or rot of the fibers that may remain after shearing.


Typically, blade assembly 20 is moved over tissue 110, in order to shear fibers disposed at various portions of the tissue. That is, face 30 is contacted with a first portion of tissue 110 in order to shear the fibers at the first portion, and is then contacted with a second portion of the tissue, and so on. This may be achieved by lifting face 30 away from the tissue before placing it in contact with the second portion of the tissue, or by sliding the face across the tissue, e.g., while it remains in contact with the tissue.


Typically, and as shown in inset “a” of FIG. 5A, sheared ends 114c are released within blade head 26 after shearing of fibers 114. For some applications, it is desirable to flush sheared fibers 114c that might otherwise accumulate within blade head 26. For such applications, sheared fibers 114c are flushed, with refuse a liquid 140, out from blade-assembly housing 22 through exhaust hole 24. Typically, a suction force flushes sheared fibers 114c from blade head 26. Further typically, and as shown, face 30 and blade array 28 are submerged in liquid 126, and blade-assembly housing 22 is shaped to define exhaust hole 24. Typically, and as shown, exhaust hole 24 is a lateral exhaust hole, disposed laterally to longitudinal axis ax18 (e.g, in a lateral wall of blade-assembly housing 22). For such applications, operation of blade assembly 20 generates a suction force which sucks liquid 126 into blade head 26 through gaps 32 in face 30, and discharges refuse liquid 140 via exhaust hole 24, e.g., laterally from the blade assembly. Typically, therefore, liquid 126 is sucked in from a distal end of blade assembly 20, and is discharged laterally from the blade assembly.


While liquid 126 is sucked through blade head 26 to exhaust hole 24, the liquid dislodges sheared fibers 114c from blade array 28, flushing the sheared fibers with the liquid, out from blade-assembly housing 22 through the exhaust hole. The use of the suction force to flush sheared fibers 114c from blade head 26 via exhaust hole 24 is hypothesized by the inventors to reduce the need for a separate blade-cleaning procedure, making the use of blade assembly 20 more time-efficient.


Typically, and as shown in inset “a” of FIG. 5A, bath 120 is filled with liquid 126 to a depth such that the liquid covers face 30 of blade head 26, but does not cover exhaust hole 24, when the face is applied to tissue 110. In this way, face 30 is typically submerged in liquid 126, whereas exhaust hole 24 is typically not submerged in liquid 126, during operation of blade assembly 20. For some applications, exhaust hole 24 is at least 1 cm (e.g., 1-10 cm, such as 1-5 cm) above face 30. It is hypothesized by the inventors that submerging face 30 in liquid 126 facilitates flushing of sheared fibers 114c from blade array 28 by sucking the liquid and sheared fibers 114c into blade head 26. It is further hypothesized by the inventors that not submerging exhaust hole 24 facilitates discharging the liquid via exhaust hole 24, by less impeding discharge of refuse liquid 140 through the exhaust hole, compared to if the exhaust hole were submerged.


For some applications, while blade array 28 is submerged in liquid 126, the movement of the blade array by motor 40 generates the suction force that sucks the liquid into blade head 26 via gaps 32, dislodges sheared fibers 114c from blade array 28 and discharges the refuse liquid 140 via exhaust hole 24. For such applications, the movement of the blade array that generates the suction force is typically rotational movement.


For some applications, e.g., as shown in FIG. 5A, refuse liquid 140 is discharged via exhaust hole 24 into bath 120.


For some applications, e.g., as shown in FIG. 5B, a pump 134 generates the suction force. For some applications, and as shown, pump 134 is connected to a refuse hose 138 configured to drain refuse liquid 140 through exhaust hole 24, away from blade assembly 20.


Although refuse hose 138 is shown as part of an embodiment including pump 134, the refuse hose may be used independently of the pump. For example, the suction force may be generated without a pump (e.g., by movement of blade array 28, as described hereinabove, mutatis mutandis), and refuse liquid 140 may be discharged via hose 138.


For some applications, and as shown, pump 134 is connected to an inlet hose 136 configured to supply fresh liquid 126 to bath 120, e.g., at the same rate at which refuse liquid 140 is discharged.


For some applications, inlet hose 136 is configured to supply fresh liquid 126 to tissue 110 independently of pump 134 (e.g., by being gravity-fed from a source of fresh liquid 126).


It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described hereinabove. Rather, the scope of the present invention includes both combinations and subcombinations of the various features described hereinabove, as well as variations and modifications thereof that am not in the prior art, which would occur to persons skilled in the art upon reading the foregoing description.

Claims
  • 1. A method for conditioning ex vivo pericardial tissue, the tissue having a parietal side, and a fibrous side from which fibers extend, the method comprising: providing a blade assembly, the blade assembly including a blade head, the blade head including a blade array and a face, the face defining gaps therein;placing the parietal side of the tissue downward against a support plate;operating a motor to move the blade array with respect to the face; andcontacting the face with the tissue such that the fibers protrude through the gaps into the blade head, and the blade array shears the fibers that protrude through the gaps into the blade head, yielding sheared fibers.
  • 2. The method according to claim 1, wherein the method further comprises mechanically securing the tissue to the support plate using a tissue restraint.
  • 3. The method according to claim 1, wherein contacting the face with the tissue comprises contacting the face with a first portion of the tissue, and wherein the method further comprises, subsequently contacting the face with a second portion of the tissue.
  • 4. The method according to claim 1, wherein the method further comprises: adding a liquid to a bath,submerging the tissue in the liquid within the bath, with the fibers facing upward, andcontacting the face with the tissue comprises contacting the face with the tissue with the face facing downward.
  • 5. The method according to claim 4, wherein: the bath is dimensioned such that the support plate is a built-in support plate, andplacing the tissue comprises placing the tissue against the built-in support plate.
  • 6. The method according to claim 4, further comprising submerging the face of the blade head in the liquid within the bath.
  • 7. The method according to claim 4, wherein the bath has a floor defining a recess dimensioned to receive the support plate, the method further involving fitting the support plate and the tissue into the recess.
  • 8. The method according to claim 1, wherein: the blade assembly further comprises a blade assembly housing shaped to define an exhaust hole,contacting the face with the tissue comprises submerging the face and the blade array in a liquid; andthe method further comprises generating a suction force that: sucks the liquid into the blade head via the gaps, anddischarges, through the exhaust hole, a refuse liquid comprising the liquid and the sheared fibers.
  • 9. The method according to claim 8, wherein discharging the refuse liquid comprises flushing the sheared fibers, with the refuse liquid, out from the blade assembly housing, laterally through the exhaust hole.
  • 10. The method according to claim 9, wherein the method further comprises draining the refuse liquid via a refuse hose.
  • 11. The method according to claim 1, wherein: the blade assembly further comprises a blade assembly housing shaped to define an exhaust hole,contacting the face with the tissue comprises submerging the face and the blade array in a liquid, andoperating the motor comprises operating the motor such that movement of the blade array with respect to the face generates a suction force that: sucks the liquid into the blade head via the gaps, anddischarges, through the exhaust hole, a refuse liquid comprising the liquid and the sheared fibers.
  • 12. The method according to claim 11, wherein operating the motor comprises operating the motor such that rotation of the blade array with respect to the face generates the suction force.
  • 13. The method according to claim 1, wherein operating the motor comprises controlling transmission of electrical power to the motor via a controller.
  • 14. The method according to claim 13, wherein controlling the transmission of electrical power comprises controlling the transmission of electrical power using a controller pack that is flexibly connected to the blade assembly via a flexible cord.
Priority Claims (1)
Number Date Country Kind
1901887 Feb 2019 GB national
PCT Information
Filing Document Filing Date Country Kind
PCT/IL2019/051398 12/23/2019 WO
Publishing Document Publishing Date Country Kind
WO2020/165889 8/20/2020 WO A
US Referenced Citations (363)
Number Name Date Kind
4972494 White et al. Nov 1990 A
5201757 Heyn et al. Apr 1993 A
5713948 Uflacker Feb 1998 A
5776140 Cottone Jul 1998 A
5957949 Leonhardt et al. Sep 1999 A
5961549 Nguyen et al. Oct 1999 A
6010530 Goicoechea Jan 2000 A
6245105 Nguyen et al. Jun 2001 B1
6254609 Vrba et al. Jul 2001 B1
6402780 Williamson, IV et al. Jun 2002 B2
6413275 Nguyen et al. Jul 2002 B1
6454799 Schreck Sep 2002 B1
6733525 Yang et al. May 2004 B2
6837902 Nguyen et al. Jan 2005 B2
7018406 Seguin et al. Mar 2006 B2
7074236 Rabkin et al. Jul 2006 B2
7261686 Couvillon, Jr. Aug 2007 B2
7585321 Cribier Sep 2009 B2
7753949 Lamphere et al. Jul 2010 B2
7811296 Goldfarb et al. Oct 2010 B2
8070802 Lamphere et al. Dec 2011 B2
8142496 Berreklouw Mar 2012 B2
8361144 Fish et al. Jan 2013 B2
8449599 Chau et al. May 2013 B2
8568475 Nguyen et al. Oct 2013 B2
8585755 Chau et al. Nov 2013 B2
8628571 Hacohen et al. Jan 2014 B1
8728155 Montorfano et al. May 2014 B2
8850898 Johnsen Oct 2014 B2
8852272 Gross et al. Oct 2014 B2
8870948 Erzberger et al. Oct 2014 B1
8870950 Hacohen Oct 2014 B2
8945177 Dell et al. Feb 2015 B2
8992604 Gross et al. Mar 2015 B2
8998982 Richter et al. Apr 2015 B2
9011468 Ketai et al. Apr 2015 B2
9017399 Gross et al. Apr 2015 B2
9023100 Quadri et al. May 2015 B2
9095434 Rowe Aug 2015 B2
9097620 Caron et al. Aug 2015 B2
9119719 Zipory et al. Sep 2015 B2
9132009 Hacohen et al. Sep 2015 B2
9180009 Majkrzak et al. Nov 2015 B2
9232995 Kovalsky et al. Jan 2016 B2
9241791 Braido et al. Jan 2016 B2
9241792 Benichou et al. Jan 2016 B2
9248014 Lane et al. Feb 2016 B2
9277994 Miller et al. Mar 2016 B2
9295551 Straubinger et al. Mar 2016 B2
9301836 Buchbinder et al. Apr 2016 B2
9320591 Bolduc Apr 2016 B2
9358107 Nguyen et al. Jun 2016 B2
9387078 Gross et al. Jul 2016 B2
9393110 Levi et al. Jul 2016 B2
9439757 Wallace et al. Sep 2016 B2
9492273 Wallace et al. Nov 2016 B2
9532870 Cooper et al. Jan 2017 B2
9554899 Granada et al. Jan 2017 B2
9561103 Granada et al. Feb 2017 B2
9597182 Straubinger et al. Mar 2017 B2
9662203 Sheahan et al. May 2017 B2
9681952 Hacohen et al. Jun 2017 B2
9763657 Hacohen et al. Sep 2017 B2
D800908 Hariton et al. Oct 2017 S
9788941 Hacohen Oct 2017 B2
9895226 Harari et al. Feb 2018 B1
9987132 Hariton et al. Jun 2018 B1
10010414 Cooper et al. Jul 2018 B2
10105222 Metchik et al. Oct 2018 B1
10123873 Metchik et al. Nov 2018 B1
10143552 Wallace et al. Dec 2018 B2
10149761 Granada et al. Dec 2018 B2
10154903 Albitov et al. Dec 2018 B2
10154906 Granada et al. Dec 2018 B2
10182908 Tubishevitz et al. Jan 2019 B2
10226341 Gross et al. Mar 2019 B2
10245143 Gross et al. Apr 2019 B2
10258471 Lutter et al. Apr 2019 B2
10292816 Raanani et al. May 2019 B2
10299927 McLean et al. May 2019 B2
10321995 Christianson et al. Jun 2019 B1
10327895 Lozonschi et al. Jun 2019 B2
10335278 McLean et al. Jul 2019 B2
10376361 Gross et al. Aug 2019 B2
10390952 Hariton et al. Aug 2019 B2
10426614 Hariton et al. Oct 2019 B2
10507108 Delgado et al. Dec 2019 B2
10512456 Hacohen et al. Dec 2019 B2
10517719 Miller et al. Dec 2019 B2
10531866 Hariton et al. Jan 2020 B2
10531872 Hacohen et al. Jan 2020 B2
10548731 Lashinski et al. Feb 2020 B2
10575948 Iamberger et al. Mar 2020 B2
10610358 Vidlund et al. Apr 2020 B2
10631871 Goldfarb et al. Apr 2020 B2
10667912 Dixon et al. Jun 2020 B2
10702385 Hacohen et al. Jul 2020 B2
10758342 Chau et al. Sep 2020 B2
10779946 Kislev et al. Sep 2020 B2
10842627 Delgado et al. Nov 2020 B2
10856972 Hariton et al. Dec 2020 B2
10856975 Hariton et al. Dec 2020 B2
10856978 Straubinger et al. Dec 2020 B2
10874514 Dixon et al. Dec 2020 B2
10888422 Hariton et al. Jan 2021 B2
10888425 Delgado et al. Jan 2021 B2
10888644 Ratz et al. Jan 2021 B2
10905548 Hariton et al. Feb 2021 B2
10905552 Dixon et al. Feb 2021 B2
10905554 Cao Feb 2021 B2
10918483 Metchik et al. Feb 2021 B2
10925732 Delgado et al. Feb 2021 B2
10945843 Delgado et al. Mar 2021 B2
10945844 McCann et al. Mar 2021 B2
10952850 Hariton et al. Mar 2021 B2
10959846 Marr et al. Mar 2021 B2
10993809 McCann et al. May 2021 B2
11026792 Kislev et al. Jun 2021 B2
11065114 Raanani et al. Jul 2021 B2
11065122 Harari et al. Jul 2021 B2
11083582 McCann et al. Aug 2021 B2
11147672 McCann et al. Oct 2021 B2
11179240 Delgado et al. Nov 2021 B2
11291545 Hacohen Apr 2022 B2
11291546 Gross et al. Apr 2022 B2
11291547 Gross et al. Apr 2022 B2
11291844 Gross Apr 2022 B2
11304805 Hariton et al. Apr 2022 B2
11304806 Hariton et al. Apr 2022 B2
11389297 Franklin et al. Jul 2022 B2
11426155 Hacohen et al. Aug 2022 B2
11517429 Gross et al. Dec 2022 B2
11517436 Hacohen Dec 2022 B2
20010005787 Oz et al. Jun 2001 A1
20020032481 Gabbay et al. Mar 2002 A1
20020151970 Garrison et al. Oct 2002 A1
20030050694 Yang et al. Mar 2003 A1
20030074059 Nguyen et al. Apr 2003 A1
20040082991 Nguyen et al. Apr 2004 A1
20040186558 Pavcnik et al. Sep 2004 A1
20040249433 Freitag Dec 2004 A1
20050080474 Andreas et al. Apr 2005 A1
20050137688 Salahieh et al. Jun 2005 A1
20050137690 Salahieh et al. Jun 2005 A1
20050137691 Salahieh et al. Jun 2005 A1
20050137693 Haug et al. Jun 2005 A1
20050137699 Salahieh et al. Jun 2005 A1
20050240200 Bergheim Oct 2005 A1
20050251251 Cribier Nov 2005 A1
20050256566 Gabbay Nov 2005 A1
20060004469 Sokel Jan 2006 A1
20060020275 Goldfarb et al. Jan 2006 A1
20060020327 Lashinski et al. Jan 2006 A1
20060052867 Revuelta et al. Mar 2006 A1
20060122692 Gilad et al. Jun 2006 A1
20060195183 Navia et al. Aug 2006 A1
20060216404 Seyler et al. Sep 2006 A1
20060259137 Artof et al. Nov 2006 A1
20060282150 Olson et al. Dec 2006 A1
20070016286 Herrmann et al. Jan 2007 A1
20070056346 Spenser et al. Mar 2007 A1
20070197858 Goldfarb et al. Aug 2007 A1
20070198077 Cully et al. Aug 2007 A1
20070213810 Newhauser et al. Sep 2007 A1
20070213813 Von Segesser et al. Sep 2007 A1
20070219630 Chu Sep 2007 A1
20080065204 Macoviak et al. Mar 2008 A1
20080071361 Tuval et al. Mar 2008 A1
20080071369 Tuval et al. Mar 2008 A1
20080147182 Righini et al. Jun 2008 A1
20080200980 Robin et al. Aug 2008 A1
20080208328 Antocci et al. Aug 2008 A1
20080208332 Lamphere et al. Aug 2008 A1
20080221672 Lamphere et al. Sep 2008 A1
20080234813 Heuser Sep 2008 A1
20080234814 Salahieh et al. Sep 2008 A1
20080243245 Thambar et al. Oct 2008 A1
20080281411 Berreklouw Nov 2008 A1
20080294248 Yang et al. Nov 2008 A1
20090005863 Goetz et al. Jan 2009 A1
20090082844 Zacharias et al. Mar 2009 A1
20090125098 Chuter May 2009 A1
20090157175 Benichou Jun 2009 A1
20090163934 Raschdorf, Jr. et al. Jun 2009 A1
20090192601 Rafiee et al. Jul 2009 A1
20090259306 Rowe Oct 2009 A1
20100022823 Goldfarb et al. Jan 2010 A1
20100023120 Holecek et al. Jan 2010 A1
20100049306 House et al. Feb 2010 A1
20100100167 Bortlein et al. Apr 2010 A1
20100161036 Pintor et al. Jun 2010 A1
20100185277 Braido et al. Jul 2010 A1
20100312333 Navia et al. Dec 2010 A1
20100324595 Linder et al. Dec 2010 A1
20100331971 Keränen et al. Dec 2010 A1
20110004299 Navia et al. Jan 2011 A1
20110021985 Spargias Jan 2011 A1
20110029072 Gabbay Feb 2011 A1
20110082538 Dahlgren et al. Apr 2011 A1
20110098802 Braido et al. Apr 2011 A1
20110112632 Chau et al. May 2011 A1
20110137397 Chau et al. Jun 2011 A1
20110137410 Hacohen Jun 2011 A1
20110144742 Madrid et al. Jun 2011 A1
20110208283 Rust Aug 2011 A1
20110208298 Tuval et al. Aug 2011 A1
20110218620 Meiri et al. Sep 2011 A1
20110224785 Hacohen Sep 2011 A1
20110245911 Quill et al. Oct 2011 A1
20110251683 Tabor Oct 2011 A1
20110276128 Cao et al. Nov 2011 A1
20110282439 Thill et al. Nov 2011 A1
20110307049 Kao Dec 2011 A1
20110319988 Schankereli et al. Dec 2011 A1
20110319989 Lane et al. Dec 2011 A1
20120016468 Robin et al. Jan 2012 A1
20120022629 Perera et al. Jan 2012 A1
20120022633 Olson et al. Jan 2012 A1
20120022639 Hacohen et al. Jan 2012 A1
20120022640 Gross et al. Jan 2012 A1
20120059458 Buchbinder et al. Mar 2012 A1
20120065464 Ellis et al. Mar 2012 A1
20120078237 Wang et al. Mar 2012 A1
20120089223 Nguyen et al. Apr 2012 A1
20120101571 Thambar et al. Apr 2012 A1
20120123529 Levi et al. May 2012 A1
20120123530 Carpentier et al. May 2012 A1
20120165930 Gifford, III et al. Jun 2012 A1
20120300063 Majkrzak et al. Nov 2012 A1
20120310328 Olson et al. Dec 2012 A1
20130018458 Yohanan et al. Jan 2013 A1
20130030519 Tran et al. Jan 2013 A1
20130035759 Gross et al. Feb 2013 A1
20130066341 Ketai et al. Mar 2013 A1
20130066342 Dell et al. Mar 2013 A1
20130150956 Yohanan et al. Jun 2013 A1
20130178930 Straubinger et al. Jul 2013 A1
20130253643 Rolando et al. Sep 2013 A1
20130261738 Clague et al. Oct 2013 A1
20130274870 Lombardi et al. Oct 2013 A1
20130304200 Mclean et al. Nov 2013 A1
20130331929 Mitra et al. Dec 2013 A1
20140000112 Braido et al. Jan 2014 A1
20140005767 Glazier et al. Jan 2014 A1
20140005778 Buchbinder et al. Jan 2014 A1
20140018915 Biadillah et al. Jan 2014 A1
20140142688 Duffy et al. May 2014 A1
20140172077 Bruchman et al. Jun 2014 A1
20140207231 Hacohen et al. Jul 2014 A1
20140214157 Börtlein et al. Jul 2014 A1
20140222136 Geist et al. Aug 2014 A1
20140222142 Kovalsky et al. Aug 2014 A1
20140236287 Clague et al. Aug 2014 A1
20140236289 Alkhatib Aug 2014 A1
20140249622 Carmi et al. Sep 2014 A1
20140257467 Lane et al. Sep 2014 A1
20140277409 Börtlein et al. Sep 2014 A1
20140277411 Börtlein et al. Sep 2014 A1
20140277412 Börtlein et al. Sep 2014 A1
20140277418 Miller Sep 2014 A1
20140324164 Gross et al. Oct 2014 A1
20140331475 Duffy et al. Nov 2014 A1
20140358222 Gorman, III et al. Dec 2014 A1
20140358224 Tegels et al. Dec 2014 A1
20150142100 Morriss et al. May 2015 A1
20150157458 Thambar et al. Jun 2015 A1
20150173896 Richter et al. Jun 2015 A1
20150173897 Raanani et al. Jun 2015 A1
20150196390 Ma et al. Jul 2015 A1
20150196393 Vidlund et al. Jul 2015 A1
20150250588 Yang et al. Sep 2015 A1
20150272730 Melnick et al. Oct 2015 A1
20150272731 Racchini et al. Oct 2015 A1
20150272734 Sheps et al. Oct 2015 A1
20150320556 Levi et al. Nov 2015 A1
20150327994 Morriss et al. Nov 2015 A1
20150328000 Ratz et al. Nov 2015 A1
20150351903 Morriss et al. Dec 2015 A1
20150351904 Cooper et al. Dec 2015 A1
20160030169 Shahriari Feb 2016 A1
20160030171 Quijano et al. Feb 2016 A1
20160095700 Righini Apr 2016 A1
20160220367 Barrett Aug 2016 A1
20160310268 Oba et al. Oct 2016 A1
20160317305 Pelled et al. Nov 2016 A1
20160324635 Vidlund et al. Nov 2016 A1
20160338706 Rowe Nov 2016 A1
20160374801 Jimenez et al. Dec 2016 A1
20160374802 Levi et al. Dec 2016 A1
20170049435 Sauer et al. Feb 2017 A1
20170056166 Ratz et al. Mar 2017 A1
20170100236 Robertson et al. Apr 2017 A1
20170135816 Lashinski et al. May 2017 A1
20170165054 Benson et al. Jun 2017 A1
20170189174 Braido et al. Jul 2017 A1
20170224323 Rowe et al. Aug 2017 A1
20170231757 Gassler Aug 2017 A1
20170281337 Campbell Oct 2017 A1
20170333187 Hariton et al. Nov 2017 A1
20180000580 Wallace et al. Jan 2018 A1
20180014930 Hariton et al. Jan 2018 A1
20180021129 Peterson et al. Jan 2018 A1
20180055629 Oba et al. Mar 2018 A1
20180098850 Rafiee et al. Apr 2018 A1
20180116790 Ratz et al. May 2018 A1
20180116843 Schreck et al. May 2018 A1
20180125644 Conklin May 2018 A1
20180132999 Perouse May 2018 A1
20180133003 Levi May 2018 A1
20180153687 Hariton et al. Jun 2018 A1
20180153695 Cunningham et al. Jun 2018 A1
20180161159 Lee et al. Jun 2018 A1
20180206982 Haivatov et al. Jul 2018 A1
20180206983 Noe et al. Jul 2018 A1
20180243086 Barbarino et al. Aug 2018 A1
20180250126 O'connor et al. Sep 2018 A1
20180250147 Syed Sep 2018 A1
20180296333 Dixon et al. Oct 2018 A1
20180296336 Cooper et al. Oct 2018 A1
20180325671 Abunassar et al. Nov 2018 A1
20180344457 Gross et al. Dec 2018 A1
20180344490 Fox et al. Dec 2018 A1
20180353294 Calomeni et al. Dec 2018 A1
20190000613 Delgado et al. Jan 2019 A1
20190015200 Delgado et al. Jan 2019 A1
20190021852 Delgado et al. Jan 2019 A1
20190038405 Iamberger et al. Feb 2019 A1
20190053896 Adamek-bowers et al. Feb 2019 A1
20190060060 Chau et al. Feb 2019 A1
20190060068 Cope et al. Feb 2019 A1
20190060070 Groothuis et al. Feb 2019 A1
20190069997 Ratz et al. Mar 2019 A1
20190083261 Perszyk et al. Mar 2019 A1
20190083262 Hariton et al. Mar 2019 A1
20190105153 Barash et al. Apr 2019 A1
20190117391 Humair Apr 2019 A1
20190167423 Hariton et al. Jun 2019 A1
20190175339 Vidlund Jun 2019 A1
20190175342 Hariton et al. Jun 2019 A1
20190183639 Moore Jun 2019 A1
20190192295 Spence et al. Jun 2019 A1
20190216602 Lozonschi Jul 2019 A1
20190262507 Adamek-bowers et al. Aug 2019 A1
20190350701 Adamek-bowers et al. Nov 2019 A1
20190365530 Hoang et al. Dec 2019 A1
20190388218 Vidlund et al. Dec 2019 A1
20190388220 Vidlund et al. Dec 2019 A1
20200000579 Manash et al. Jan 2020 A1
20200015964 Noe et al. Jan 2020 A1
20200060818 Geist et al. Feb 2020 A1
20200085578 Kislev et al. Mar 2020 A1
20200281723 Harari et al. Sep 2020 A1
20200405486 Kislev et al. Dec 2020 A1
20210106419 Abunassar Apr 2021 A1
20210113331 Quadri et al. Apr 2021 A1
20210137680 Kizuka et al. May 2021 A1
20210251759 Kislev et al. Aug 2021 A1
20210259835 Tyler, II et al. Aug 2021 A1
20220000612 Hacohen Jan 2022 A1
20220023036 Levi et al. Jan 2022 A1
20220061984 Humair et al. Mar 2022 A1
20220105238 Reimer et al. Apr 2022 A1
20220151779 Pintor May 2022 A1
Foreign Referenced Citations (65)
Number Date Country
103974674 Aug 2014 CN
0170262 Feb 1986 EP
1264582 Dec 2002 EP
1637092 Mar 2006 EP
2641569 Sep 2013 EP
2349124 Oct 2018 EP
3583922 Dec 2019 EP
3270825 Apr 2020 EP
2485795 Sep 2020 EP
844190 Aug 1960 GB
S53152790 Dec 1978 JP
20010046894 Jun 2001 KR
1998043557 Oct 1998 WO
0182832 Nov 2001 WO
2004028399 Apr 2004 WO
2006007389 Jan 2006 WO
2006113906 Oct 2006 WO
2006128193 Nov 2006 WO
2007047488 Apr 2007 WO
2010006627 Jan 2010 WO
2010027485 Mar 2010 WO
2010057262 May 2010 WO
2011057087 May 2011 WO
2011072084 Jun 2011 WO
2011144351 Nov 2011 WO
2012011108 Jan 2012 WO
2012048035 Apr 2012 WO
2012177942 Dec 2012 WO
2012178115 Dec 2012 WO
2013021374 Feb 2013 WO
2013021375 Feb 2013 WO
2013028387 Feb 2013 WO
2013059743 Apr 2013 WO
2013059747 Apr 2013 WO
2013072496 May 2013 WO
2013078497 Jun 2013 WO
2013114214 Aug 2013 WO
2013175468 Nov 2013 WO
2014076696 May 2014 WO
2014115149 Jul 2014 WO
2014121275 Aug 2014 WO
2014121280 Aug 2014 WO
2014144937 Sep 2014 WO
2014164364 Oct 2014 WO
2016016899 Feb 2016 WO
2016125160 Aug 2016 WO
2016183526 Nov 2016 WO
2018025263 Feb 2018 WO
2018029680 Feb 2018 WO
2018039631 Mar 2018 WO
2019026059 Feb 2019 WO
2019027507 Feb 2019 WO
2019030753 Feb 2019 WO
2019077595 Apr 2019 WO
2019086958 May 2019 WO
2019116369 Jun 2019 WO
2019138400 Jul 2019 WO
2019195860 Oct 2019 WO
2019202579 Oct 2019 WO
2020058972 Mar 2020 WO
2020165889 Aug 2020 WO
2021156866 Aug 2021 WO
2021186424 Sep 2021 WO
2022046568 Mar 2022 WO
2022061017 Mar 2022 WO
Non-Patent Literature Citations (155)
Entry
An Office Action dated Sep. 9, 2021, which issued during the prosecution of U.S. Appl. No. 16/768,909.
An Office Action dated Sep. 15, 2021, which issued during the prosecution of U.S. Appl. No. 16/135,599.
An Office Action dated Oct. 14. 2021, which issued during the prosecution of U.S. Appl. No. 16/680,739.
An Office Action dated Oct. 21, 2021, which issued during the prosecution of U.S. Appl. No. 17/335,845.
European Search Report dated Oct. 11, 2021 which issued during the prosecution of Applicant's European App No. 21176010.3.
Fann, James I., et al. “Beating heart catheter-based edge-to-edge mitral valve procedure in a porcine model: efficacy and healing response.” Circulation 110.8 (2004): 988-993.
Feldman, Ted, et al. “Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort.” Journal of the American College of Cardiology 54.8 (2009): 686-694.
IPR2021-00383 Patent Owner's Contingent Motion To Amend Under 37 C.F.R. §42.121 dated Oct. 13, 2021.
IPR2021-00383 Patent Owner's Response Pursuant to 37 C.F.R. § 42.120 dated Oct. 13, 2021.
IPR2021-00383 Second Declaration of Dr. Michael Sacks dated Oct. 13, 2021.
An Office Action dated Oct. 21, 2021, which issued during the prosecution of U.S. Appl. No. 17/306,231.
Maisano, Francesco, et al. “The evolution from surgery to percutaneous mitral valve interventions: the role of the edge-to-edge technique.” Journal of the American College of Cardiology 58.21 (2011): 2174-2182.
IPR2021-00383 Deposition of Dr. Ivan Vesely, dated Sep. 22, 2021.
Cardiovalve Exhibit 2009—Percutaneous Mitral Leaflet Repair: MitraClip® Therapy for Mitral Regurgitation (2012).
Feldman, Ted, et al. “Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial.” Journal of the American College of Cardiology 46.11 (2005): 2134-2140.
An Office Action summarized English translation and Search Report dated Oct. 8, 2021, which issued during the prosecution of Chinese Patent Application No. 201780061210.3.
An Office Action dated Nov. 4, 2021, which issued during the prosecution of U.S. Appl. No. 17/366,711.
An Office Action summarized English translation and Search Report dated Aug. 12, 2021, which issued during the prosecution of Chinese Patent Application No. 201880058940.2.
Maisano, F., et al. “The edge-to-edge technique: a simplified method to correct mitral insufficiency.” European journal of cardio-thoracic surgery 13.3 (1998): 240-246.
Fucci, C., et al. “Improved results with mitral valve repair using new surgical techniques.” European journal of cardio-thoracic surgery 9.11 (1995): 621-627.
An Office Action dated Jul. 27, 2022, which issued during the prosecution of U.S. Appl. No. 16/881,350.
An Office Action dated Sep. 21, 2022, which issued during the prosecution of U.S. Appl. No. 16/776,581.
An Office Action dated Jul. 20, 2022, which issued during the prosecution of U.S. Appl. No. 17/101,787.
An Office Action dated Sep. 16, 2022, which issued during the prosecution of U.S. Appl. No. 16/135,466.
An Office Action dated Aug. 1, 2022, which issued during the prosecution of European Patent Application No. 18826823.9.
European Search Report dated Sep. 6, 2022 which issued during the prosecution of Applicant's European App No. 22161862.2.
IPR2021-01051 Petitioners' Reply to Preliminary Guidance dated Aug. 2, 2022.
IPR2021-01051 Patent Owner's Sur-Reply to Petitioners' Reply to Preliminary Guidance dated Aug. 23, 2022.
An Office Action dated Aug. 5, 2022, which issued during the prosecution of U.S. Appl. No. 16/760,147.
An Office Action dated Sep. 8, 2022, which issued during the prosecution of U.S. Appl. No. 16/896,858.
An Office Action dated Sep. 29, 2022, which issued during the prosecution of U.S. Appl. No. 17/010,886.
An Office Action dated Sep. 29, 2022, which issued during the prosecution of U.S. Appl. No. 16/656,790.
Notice of Allowance dated Sep. 20, 2023, which issued during the prosecution of U.S. Appl. No. 17/839,538.
An Office Action dated Oct. 13, 2023, which issued during the prosecution of U.S. Appl. No. 17/181,722.
Grounds of Opposition to European Patent No. EP 2 948 103, filed Sep. 6, 2023.
An Office Action dated Aug. 31, 2023, which issued during the prosecution of U.S. Appl. No. 17/397,235.
An Office Action dated Sep. 8, 2023, which issued during the prosecution of U.S. Appl. No. 18/216,391.
An Office Action dated Sep. 8, 2023, which issued during the prosecution of U.S. Appl. No. 18/218,419.
Opposition to European Patent No. EP 2 948 103, filed Sep. 6, 2023.
An International Search Report and a Written Opinion both dated Aug. 23, 2023, 2023, which issued during the prosecution of Applicant's PCT/IL2023/050586.
An Office Action dated Aug. 3, 2023, which issued during the prosecution of U.S. Appl. No. 17/683,875.
An International Search Report and a Written Opinion both dated Sep. 13, 2023, which issued during the prosecution of Applicant's PCT/IL2023/050587.
An Office Action dated Feb. 28, 2024, which issued during the prosecution of Canadian Patent Application No. 3,129,355.
An Office Action dated Jan. 26, 2022, which issued during the prosecution of U.S. Appl. No. 16/888,210.
Notice of Allowance dated Jan. 31, 2022, which issued during the prosecution of U.S. Appl. No. 17/479,418.
An Office Action dated Mar. 18, 2022, which issued during the prosecution of U.S. Appl. No. 16/746,489.
Notice of Allowance dated Mar. 22, 2022, which issued during the prosecution of U.S. Appl. No. 17/366,711.
Notice of Allowance dated Mar. 4, 2022, which issued during the prosecution of U.S. Appl. No. 16/768,909.
An Office Action dated Dec. 9, 2021, which issued during the prosecution of U.S. Appl. No. 16/135,969.
An Office Action dated Jan. 24, 2022, which issued during the prosecution of U.S. Appl. No. 16/135,466.
An Office Action dated Apr. 11, 2022, which issued during the prosecution of U.S. Appl. No. 17/473,472.
IPR2021-00383 Preliminary Guidance dated Jan. 31, 2022.
An International Search Report and a Written Opinion both dated May 3, 2022, which issued during the prosecution of Applicant's PCT/IL2021/051433.
An Office Action dated Jul. 8, 2022, which issued during the prosecution of U.S. Appl. No. 16/144,054.
An Office Action dated Jun. 28, 2022, which issued during the prosecution of U.S. Appl. No. 16/135,969.
An Office Action together with an English Summary dated May 7, 2022 which issued during the prosecution of Chinese Patent Application No. 201880058940.2.
Ex Parte Quayle dated May 2, 2022, which issued during the prosecution of U.S. Appl. No. 16/879,952.
IPR2021-00383 Final Written Decision dated Jul. 18, 2022.
IPR2021-01051 Preliminary Guidance Patent Owner's Motion to Amend dated Jun. 24, 2022.
Notice of Allowance dated May 4, 2022, which issued during the prosecution of U.S. Appl. No. 16/680,739.
An Office Action dated Nov. 25, 2021, which issued during the prosecution of European Patent Application No. 18826823.9.
IPR2021-01051 Institution decision dated Dec. 10, 2021.
Notice of Allowance dated Dec. 7, 2021, which issued during the prosecution of U.S. Appl. No. 17/394,807.
Notice of Allowance dated Dec. 6, 2021, which issued during the prosecution of U.S. Appl. No. 16/738,516.
Notice of Allowance dated Dec. 29, 2021, which issued during the prosecution of U.S. Appl. No. 17/210,183.
IPR2021-00383 Petitioners' Reply to Patent Owner's Response dated Jan. 5, 2022.
IPR2021-00383 Petitioners' Opposition to Patent Owner's Contingent Motion to Amend dated Jan. 5, 2022.
An Office Action dated Sep. 22, 2021, which issued during the prosecution of European Patent Application No. 20714289.4.
Summary of Examination Notice dated Jan. 6, 2022, which issued during the prosecution of Chinese Patent Application No. 201880064313.X.
An Office Action dated Jan. 12, 2022, which issued during the prosecution of U.S. Appl. No. 17/101,787.
Notice of Allowance dated Dec. 22, 2017, which issued during the prosecution of U.S. Appl. No. 15/788,407.
An International Search Report and a Written Opinion both dated Jun. 20, 2018, which issued during the prosecution of Applicant's PCT/IL2018/050024.
An International Preliminary Report on Patentability dated Apr. 21, 2020, which issued during the prosecution of Applicant's PCT/IL2018/050024.
An International Search Report and a Written Opinion both dated Nov. 9, 2018, which issued during the prosecution of Applicant's PCT/IL2018/050869.
An International Search Report and a Written Opinion both dated May 13, 2019, which issued during the prosecution of Applicant's PCT/IL2018/051350.
An International Search Report and a Written Opinion both dated Apr. 25, 2019, which issued during the prosecution of Applicant's PCT/IL2019/050142.
An International Search Report and a Written Opinion both dated Jan. 25, 2019, which issued during the prosecution of Applicant's PCT/IL2018/051122.
An International Search Report and a Written Opinion both dated Dec. 5, 2018, which issued during the prosecution of Applicant's PCT/IL2018/050725.
An International Preliminary Report on Patentability dated Feb. 12. 2019, which issued during the prosecution of Applicant's PCT/IL2017/050873.
An International Preliminary Report on Patentability dated Feb. 5, 2019, which issued during the prosecution of Applicant's PCT/IL2017/050849.
An Office Action dated Mar. 25, 2019, which issued during the prosecution of European Patent Application No. 14710060.6.
An Office Action dated Oct. 25, 2018, which issued during the prosecution of U.S. Appl. No. 14/763,004.
An Office Action dated Mar. 4, 2019, which issued during the prosecution of U.S. Appl. No. 14/763,004.
An Office Action dated Jan. 9, 2019, which issued during the prosecution of U.S. Appl. No. 15/329,920.
An Office Action dated Jan. 30, 2019, which issued during the prosecution of U.S. Appl. No. 15/872,501.
An Office Action dated May 14, 2020, which issued during the prosecution of U.S. Appl. No. 16/132,937.
An Office Action dated Feb. 5, 2019, which issued during the prosecution of U.S. Appl. No. 15/899,858.
An Office Action dated May 23, 2019, which issued during the prosecution of U.S. Appl. No. 15/668,659.
An Office Action dated May 1, 2019, which issued during the prosecution of U.S. Appl. No. 15/691,032.
An Office Action dated May 16, 2019, which issued during the prosecution of U.S. Appl. No. 15/433,547.
An Office Action dated Aug. 1, 2019, which issued during the prosecution of U.S. Appl. No. 15/668,559.
An Office Action dated Jun. 25, 2019, which issued during the prosecution of U.S. Appl. No. 15/329,920.
An Office Action dated Nov. 1, 2019, which issued during the prosecution of U.S. Appl. No. 15/872,501.
An Office Action dated Aug. 16, 2019, which issued during the prosecution of U.S. Appl. No. 15/668,659.
An Office Action dated Jun. 19, 2019, which issued during the prosecution of U.S. Appl. No. 15/682,789.
An Office Action dated Jun. 14, 2019, which issued during the prosecution of U.S. Appl. No. 15/703,385.
An Office Action dated Oct. 4, 2019, which issued during the prosecution of U.S. Appl. No. 16/183,140.
An Office Action dated Sep. 13, 2019, which issued during the prosecution of U.S. Appl. No. 16/460,313.
An Office Action dated Nov. 26, 2019, which issued during the prosecution of U.S. Appl. No. 16/532,945.
An Office Action dated Jun. 13. 2019, which issued during the prosecution of U.S. Appl. No. 16/388,038.
An Office Action dated Jan. 6, 2020, which issued during the prosecution of U.S. Appl. No. 16/660,231.
Notice of Allowance dated Oct. 19, 2020, which issued during the prosecution of U.S. Appl. No. 16/937,216.
An Office Action dated Aug. 13, 2019, which issued during the prosecution of UK Patent Application No. 1901887.8.
An Office Action dated Dec. 31, 2019, which issued during the prosecution of U.S. Appl. No. 16/183,140.
An Office Action dated Jan. 14, 2020, which issued during the prosecution of U.S. Appl. No. 16/284,331.
Notice of Allowance dated Jan. 13, 2020, which issued during the prosecution of U.S. Appl. No. 15/956,956.
European Search Report dated Mar. 5, 2020 which issued during the prosecution of Applicant's European App No. 17752184.6.
European Search Report dated Mar. 4, 2020 which issued during the prosecution of Applicant's European App No. 16706913.7.
Notice of Allowance dated Mar. 12, 2020, which issued during the prosecution of U.S. Appl. No. 16/460,313.
An Office Action dated Jan. 9, 2020, which issued during the prosecution of U.S. Appl. No. 15/600,190.
An Office Action dated Jan. 3, 2020, which issued during the prosecution of U.S. Appl. No. 16/678,355.
An Office Action dated Feb. 6, 2020, which issued during the prosecution of U.S. Appl. No. 15/668,659.
An Office Action dated Sep. 24, 2020, which issued during the prosecution of U.S. Appl. No. 16/811,732.
Symetis S.A.: “Acurate neo™ Aortic Bioprosthesis for Implantation using the Acurate neo™ TA Transapical Delivery System in Patients with Severe Aortic Stenosis,” Clinical Investigation Plan, Protocol No. 2015-01, Version # 2 (2015): 1-76.
An Office Action dated Nov. 30, 2020, which issued during the prosecution of U.S. Appl. No. 16/138,129.
Notice of Allowance dated Nov. 19, 2020, which issued during the prosecution of U.S. Appl. No. 16/318,025.
An Office Action dated Oct. 5, 2020, which issued during the prosecution of Canadian Patent Application No. 2,973,940.
An International Preliminary Report on Patentability dated Oct. 20, 2020, which issued during the prosecution of Applicant's PCT/IL2019/050142.
An Office Action summarized English translation and Search Report dated Nov. 25. 2020, which issued during the prosecution of Chinese Patent Application No. 201910449820.1.
An International Search Report and a Written Opinion both dated Jan. 28, 2020, which issued during the prosecution of Applicant's PCT/IL2019/051031.
European Search Report dated May 7, 2021 which issued during the prosecution of Applicant's European App No. 18700954.3.
Sündermann, Simon H., et al. “Feasibility of the Engager™ aortic transcatheter valve system using a flexible over-the-wire design.” European Journal of Cardio-Thoracic Surgery 42.4 (2012): e48-e52.
Serruys, P. W., Piazza, N., Cribier, A., Webb, J., Laborde, J. C., & de Jaegere, P. (Eds.). (2009). Transcatheter aortic valve implantation: tips and tricks to avoid failure. CRC Press.—Screenshots from Google Books downloaded from: https://books.google.co.il/books?id=ELzLBQAAQBAJ&lpg=PA198&ots=soqWrDH-y_&dq=%20%22Edwards%20SAPIEN%22&lr&pg=PA20#v=onepage&q=%22Edwards%20SAPIEN%22&f=false ; Downloaded on Jun. 18, 2020.
Notice of Allowance dated May 7, 2020, which issued during the prosecution of U.S. Appl. No. 16/637,166.
An Office Action dated Aug. 7, 2020, which issued during the prosecution of U.S. Appl. No. 15/668,659.
Notice of Allowance dated Jul. 29, 2020, which issued during the prosecution of U.S. Appl. No. 16/132,937.
Notice of Allowance dated Sep. 10, 2020, which issued during the prosecution of U.S. Appl. No. 15/600,190.
An Office Action dated Jul. 29, 2020, which issued during the prosecution of U.S. Appl. No. 16/269,328.
Notice of Allowance dated Aug. 26, 2020, which issued during the prosecution of U.S. Appl. No. 16/269,328.
An Office Action dated Jul. 14, 2020, which issued during the prosecution of U.S. Appl. No. 16/324,339.
Notice of Allowance dated Aug. 28, 2020, which issued during the prosecution of U.S. Appl. No. 16/324,339.
An Office Action summarized English translation and Search Report dated Jul. 3, 2020, which issued during the prosecution of Chinese Patent Application No. 201780061210.3.
Tchetche, D. and Nicolas M. Van Mieghem: “New-generation TAVI devices: description and specifications” EuroIntervention, 2014, No. 10:U90-U100.
An International Search Report and a Written Opinion both dated Jun. 24, 2020, which issued during the prosecution of Applicant's PCT/IL2019/051398.
Notice of Allowance dated Feb. 9, 2021, which issued during the prosecution of U.S. Appl. No. 16/937,216.
Notice of Allowance dated Dec. 23, 2020, which issued during the prosecution of U.S. Appl. No. 16/937,216.
Notice of Allowance dated Mar. 31, 2021, which issued during the prosecution of U.S. Appl. No. 16/756,235.
Notice of Allowance dated Mar. 22, 2021, which issued during the prosecution of U.S. Appl. No. 16/756,235.
An International Search Report and a Written Opinion both dated Feb. 23, 2021, which issued during the prosecution of Applicant's PCT/IL2020/050315.
An International Preliminary Report on Patentability dated Mar. 9, 2021, which issued during the prosecution of Applicant's PCT/IL2019/051031.
European Search Report dated Jun. 10, 2021 which issued during the prosecution of Applicant's European App No. 21157988.3.
An Invitation to pay additional fees dated May 19, 2021, which issued during the prosecution of Applicant's PCT/IL2021/050132.
An International Search Report and a Written Opinion both dated Jul. 12, 2021, which issued during the prosecution of Applicant's PCT/IL2021/050132.
IPR2021-00383 Petitioners' Authorized Reply to Patent Owner's Preliminary Response dated May 27, 2021.
Exhibit 1014—Transcript of proceedings held May 20, 2021 (Edwards Lifesciences vs. Cardiovalve).
Exhibit 1015—Facilitate, Meriam-Webster.com, https://www.merriamwebster.com/dictionary/facilitate (visited May 26, 2021).
Patent Owner's Authorized Surreply to Petitioner's Reply to Patent Owner's Preliminary Response dated Jun. 4, 2021(Edwards Lifesciences vs. Cardiovalve).
An Office Action dated Aug. 18, 2021, which issued during the prosecution of U.S. Appl. No. 17/210,183.
Institution decision dated Jul. 20, 2021(Edwards Lifesciences vs. Cardiovalve).
An International Preliminary Report on Patentability dated Aug. 10, 2021, which issued during the prosecution of Applicant's PCT/IL2019/051398.
Petition for Inter Partes Review of U.S. Pat. No. 10,702,385—dated Jun. 4, 2021.
Declaration of Ivan Vesely, Ph.D. in Support of Petition for Inter Partes Review of U.S. Pat. No. 10,702,385—dated Jun. 4, 2021.
Declaration of Dr. Ivan Vesely, Ph.D. in Support of Petition for Inter Partes Review of U.S. Pat. No. 10,226,341—dated Dec. 17, 2020.
Petition for Inter Partes Review of U.S. Pat. No. 10,226,341 and Exhibits 1001-1013—dated Dec. 29, 2020.
English Translation of Office Action dated May 14, 2024, which issued during the prosecution of Chinese Patent Application No. 201980095188.3.
Related Publications (1)
Number Date Country
20220133342 A1 May 2022 US